BRIEF published on 09/25/2024 at 13:41, 1 month 27 days ago Dalata Hotel Group PLC Announces UBS's Major Holdings Notification Voting Rights Major Holdings Financial Instruments Dalata Hotel Group UBS Group AG
PRESS RELEASE published on 09/25/2024 at 13:36, 1 month 27 days ago Dalata Hotel Group PLC: HOL-Holding(s) in Company* UBS Group AG, through UBS Investment Bank & Wealth Management, notified a 3.25% voting rights stake in Dalata Hotel Group PLC to the Central Bank of Ireland Wealth Management Dalata Hotel Group Plc Central Bank Of Ireland UBS Group AG UBS Investment Bank
BRIEF published on 09/20/2024 at 11:25, 2 months 2 days ago Dalata Hotel Group PLC: Notification of Major Holdings Major Holdings Financial Instruments Dalata Hotel Group Equity Swaps Helikon Investments
PRESS RELEASE published on 09/20/2024 at 11:20, 2 months 2 days ago Dalata Hotel Group PLC: HOL-Holding(s) in Company* Helikon Investments Limited, based in London, UK, crosses 8% threshold in Dalata Hotel Group PLC. Acquisition of financial instruments disclosed Dalata Hotel Group Plc London Financial Instruments Helikon Investments Limited 8% Threshold
BRIEF published on 09/16/2024 at 16:10, 2 months 6 days ago Dalata Hotel Group PLC: Notification of Major Holdings Voting Rights Major Holdings Dalata Hotel Group Equity Swaps Helikon Investments
PRESS RELEASE published on 09/16/2024 at 16:05, 2 months 6 days ago Dalata Hotel Group PLC: HOL-Holding(s) in Company* Helikon Investments Limited, based in London, UK, discloses holding above 7% voting rights in Dalata Hotel Group PLC on 10th September 2024 Voting Rights Notification Dalata Hotel Group Plc London Helikon Investments Limited
BRIEF published on 09/04/2024 at 08:10, 2 months 18 days ago Dalata Hotel Group PLC Announces €30 Million Share Buy-back Share Buy-back Euronext Dublin Capital Reduction Dalata Hotel Group J&E Davy
BRIEF published on 09/04/2024 at 08:05, 2 months 18 days ago Dalata Hotel Group Reports H1 2024 Results with Revenue Growth Share Buy-back Revenue Growth Dalata Hotel Group Expansion Plans H1 2024 Results
PRESS RELEASE published on 09/04/2024 at 08:05, 2 months 18 days ago Dalata Hotel Group PLC: Share buy-back Dalata Hotel Group PLC announces a €30 million share buy-back program, in line with its capital allocation strategy. The initiative will be executed independently by J&E Davy and Berenberg Share Buy-back Capital Allocation Dalata Hotel Group J&E Davy Berenberg
PRESS RELEASE published on 09/04/2024 at 08:00, 2 months 18 days ago Dalata Hotel Group PLC: H1 2024 Results Dalata Hotel Group PLC announces H1 2024 results with solid performance despite cost inflation. Share buy-back and executive appointments. Growth strategy and sustainability updates Growth Strategy Share Buy-back Dalata Hotel Group Plc Executive Appointments H1 2024 Results
Published on 11/22/2024 at 23:55, 1 hour 4 minutes ago Boron One Announces Early Warrant Exercise Incentive Program
Published on 11/22/2024 at 23:30, 1 hour 29 minutes ago Electric Royalties Enters Into Definitive Agreement to Acquire 0.75% Gross Revenue Royalty on Producing Punitaqui Copper Mine in Chile
Published on 11/22/2024 at 23:05, 1 hour 54 minutes ago Nexa Resources Announces Closing Transaction of Pukaqaqa Project Sale to Olympic
Published on 11/22/2024 at 22:30, 2 hours 29 minutes ago Delaforce Energy Corp. Announces Acquisition of Bouchard Well Service Ltd.
Published on 11/22/2024 at 18:14, 6 hours 44 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 11/22/2024 at 17:53, 7 hours 5 minutes ago Funding Circle Plc: POS-Transaction in Own Shares
Published on 11/22/2024 at 16:55, 8 hours 3 minutes ago EQS-Adhoc: Comment on withdrawn non-binding offer
Published on 11/22/2024 at 16:00, 8 hours 59 minutes ago Proposed cancellation of admission to trading
Published on 11/21/2024 at 06:58, 1 day 18 hours ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 2 days 5 hours ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 2 days 7 hours ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 2 days 7 hours ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
